annual CFO:
-$116.64M-$37.15M(-46.73%)Summary
- As of today (August 29, 2025), GPCR annual cash flow from operations is -$116.64 million, with the most recent change of -$37.15 million (-46.73%) on December 31, 2024.
- During the last 3 years, GPCR annual CFO has fallen by -$84.48 million (-262.67%).
- GPCR annual CFO is now -716.61% below its all-time high of -$14.28 million, reached on December 1, 2020.
Performance
GPCR Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$54.75M-$2.44M(-4.67%)Summary
- As of today (August 29, 2025), GPCR quarterly cash flow from operations is -$54.75 million, with the most recent change of -$2.44 million (-4.67%) on June 30, 2025.
- Over the past year, GPCR quarterly CFO has dropped by -$28.38 million (-107.63%).
- GPCR quarterly CFO is now -450.62% below its all-time high of -$9.94 million, reached on June 1, 2022.
Performance
GPCR quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$163.35M-$28.38M(-21.03%)Summary
- As of today (August 29, 2025), GPCR TTM cash flow from operations is -$163.35 million, with the most recent change of -$28.38 million (-21.03%) on June 30, 2025.
- Over the past year, GPCR TTM CFO has dropped by -$60.33 million (-58.56%).
- GPCR TTM CFO is now -1113.39% below its all-time high of -$13.46 million, reached on March 1, 2022.
Performance
GPCR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
GPCR Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -46.7% | -107.6% | -58.6% |
| 3 y3 years | -262.7% | -450.6% | -597.9% |
| 5 y5 years | -716.6% | - | - |
GPCR Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -262.7% | at low | -450.6% | at low | -597.9% | at low |
| 5 y | 5-year | -716.6% | at low | -450.6% | at low | -1113.4% | at low |
| alltime | all time | -716.6% | at low | -450.6% | at low | -1113.4% | at low |
GPCR Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$54.75M(+4.7%) | -$163.35M(+21.0%) |
| Mar 2025 | - | -$52.30M(+43.5%) | -$134.97M(+15.7%) |
| Dec 2024 | -$116.64M(+46.7%) | -$36.44M(+83.4%) | -$116.69M(+14.2%) |
| Sep 2024 | - | -$19.87M(-24.7%) | -$102.17M(-0.8%) |
| Jun 2024 | - | -$26.37M(-22.5%) | -$103.02M(+10.5%) |
| Mar 2024 | - | -$34.02M(+55.3%) | -$93.27M(+17.4%) |
| Dec 2023 | -$79.49M | -$21.91M(+5.7%) | -$79.42M(+38.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$20.72M(+24.7%) | -$57.51M(+56.3%) |
| Jun 2023 | - | -$16.61M(-17.7%) | -$36.79M(+22.1%) |
| Mar 2023 | - | -$20.18M(+102.9%) | -$30.12M(+28.7%) |
| Dec 2022 | -$46.12M(+43.4%) | - | - |
| Jun 2022 | - | -$9.94M(-26.1%) | -$23.41M(+73.9%) |
| Mar 2022 | - | -$13.46M | -$13.46M |
| Dec 2021 | -$32.16M(+125.2%) | - | - |
| Dec 2020 | -$14.28M | - | - |
FAQ
- What is Structure Therapeutics Inc. annual cash flow from operations?
- What is the all time high annual CFO for Structure Therapeutics Inc.?
- What is Structure Therapeutics Inc. annual CFO year-on-year change?
- What is Structure Therapeutics Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Structure Therapeutics Inc.?
- What is Structure Therapeutics Inc. quarterly CFO year-on-year change?
- What is Structure Therapeutics Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Structure Therapeutics Inc.?
- What is Structure Therapeutics Inc. TTM CFO year-on-year change?
What is Structure Therapeutics Inc. annual cash flow from operations?
The current annual CFO of GPCR is -$116.64M
What is the all time high annual CFO for Structure Therapeutics Inc.?
Structure Therapeutics Inc. all-time high annual cash flow from operations is -$14.28M
What is Structure Therapeutics Inc. annual CFO year-on-year change?
Over the past year, GPCR annual cash flow from operations has changed by -$37.15M (-46.73%)
What is Structure Therapeutics Inc. quarterly cash flow from operations?
The current quarterly CFO of GPCR is -$54.75M
What is the all time high quarterly CFO for Structure Therapeutics Inc.?
Structure Therapeutics Inc. all-time high quarterly cash flow from operations is -$9.94M
What is Structure Therapeutics Inc. quarterly CFO year-on-year change?
Over the past year, GPCR quarterly cash flow from operations has changed by -$28.38M (-107.63%)
What is Structure Therapeutics Inc. TTM cash flow from operations?
The current TTM CFO of GPCR is -$163.35M
What is the all time high TTM CFO for Structure Therapeutics Inc.?
Structure Therapeutics Inc. all-time high TTM cash flow from operations is -$13.46M
What is Structure Therapeutics Inc. TTM CFO year-on-year change?
Over the past year, GPCR TTM cash flow from operations has changed by -$60.33M (-58.56%)